LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - BioMarin Pharmaceutical (NASDAQ: BMRN)

Follow NASDAQ:BMRN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ BMRN BioMarin Pharmaceutical
Hubbard Cristin / officer: EVP, Chief Commercial Officer
04/30/2025
Buy
$54.14
273
$15K
32,973
NASDAQ BMRN BioMarin Pharmaceutical
Hubbard Cristin / officer: EVP, Chief Commercial Officer
05/02/2025
Sell
$64.92
273
$18K
32,700
NASDAQ BMRN BioMarin Pharmaceutical
Burkhart Erin / officer: GVP, Chief Accounting Officer
03/19/2025
Sell
$71.52
1,295
$93K
16,955
NASDAQ BMRN BioMarin Pharmaceutical
Burkhart Erin / officer: GVP, Chief Accounting Officer
03/17/2025
Buy
$71.55
9,230
$660K
9,230
NASDAQ BMRN BioMarin Pharmaceutical
Davis George Eric / officer: EVP, Chief Legal Officer
03/17/2025
Buy
$71.55
30,020
$2.148M
30,020
NASDAQ BMRN BioMarin Pharmaceutical
Hubbard Cristin / officer: EVP, Chief Commercial Officer
03/17/2025
Buy
$71.55
30,880
$2.209M
30,880
NASDAQ BMRN BioMarin Pharmaceutical
Friberg Gregory R / officer: EVP, Chief R&D Officer
03/17/2025
Buy
$71.55
41,170
$2.946M
41,170
NASDAQ BMRN BioMarin Pharmaceutical
Guyer Charles Greg / officer: EVP, Chief Technical Officer
03/17/2025
Buy
$71.55
30,880
$2.209M
30,880
NASDAQ BMRN BioMarin Pharmaceutical
Mueller Brian / officer: EVP, Chief Financial Officer
03/17/2025
Buy
$71.55
38,590
$2.761M
38,590
NASDAQ BMRN BioMarin Pharmaceutical
Hardy Alexander / director, officer: Chief Executive Officer
03/17/2025
Buy
$71.55
61,750
$4.418M
61,750

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous